Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Teriparatide sustained-release microsphere and preparation method thereof

A technology of sustained-release microspheres and teriparatide, applied in the field of medicine, can solve the problems of injection site damage, lack of sustained-release, and low patient compliance, achieving high encapsulation rate, reducing the probability of infection, The effect of reducing the number of doses

Active Publication Date: 2015-03-18
HYBIO PHARMA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the existing teriparatide drug does not have sustained-release properties and needs to be injected subcutaneously every day. For patients, such frequent injections for a long time will bring great inconvenience to the patients, and the patient's compliance is low. There are also varying degrees of damage to the
And if the injection pen is damaged during long-term use, the medicine in it may be infected

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Teriparatide sustained-release microsphere and preparation method thereof
  • Teriparatide sustained-release microsphere and preparation method thereof
  • Teriparatide sustained-release microsphere and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0050] The preparation method of the teriparatide sustained-release microspheres provided by the present invention comprises the following steps: taking a carrier and teriparatide and dissolving them in an organic solvent, mixing them with an aqueous solution of a surfactant, and emulsifying to obtain an emulsion; taking the emulsion and surfactant The aqueous solution of the agent is mixed, the organic solvent is removed, purified and dried.

[0051] The organic solvent is one or a mixture of two or more of dichloromethane, acetone, ethyl acetate, acetonitrile, methyl acetate, 1,4-dioxane, ethanol, and dimethylformamide.

[0052] In the preparation method of the teriparatide sustained-release microspheres provided by the present invention, the mass volume concentration of the surfactant in the aqueous solution of the surfactant mixed with the organic solvent containing the carrier and the teriparatide is 1% to 10%.

[0053] The surfactant in the aqueous solution of the surfac...

Embodiment 1

[0080] Example 1 Preparation of Teriparatide Sustained-release Microspheres by Emulsion Solvent Evaporation Method

[0081] Accurately weigh 2g of lactic acid-glycolic acid copolymer (85:15, Mw=15000) and 200mg of teriparatide, dissolve in 40mL of dichloromethane as the dispersed phase; add the above dispersed phase slowly in a water bath at 10°C Put it into 200mL aqueous solution containing 1% polyvinyl alcohol, emulsify for 1 hour, the emulsification condition is 1000 rpm, stir while adding; add the obtained emulsion into 500mL aqueous solution containing 0.1% polyvinyl alcohol, the temperature is 25 ℃, stir The organic solvent was volatilized in 4 hours to form solidified microspheres; the solution obtained above was collected by centrifugation at 3000 rpm, washed three times with purified water to remove the drug and polyvinyl alcohol on the surface of the microspheres, and dried in vacuum for two days to obtain Teriparatide extended-release microspheres.

Embodiment 2

[0082] Example 2 Preparation of Teriparatide Sustained Release Microspheres by Emulsion Solvent Evaporation Method

[0083] Accurately weigh 10g of lactic acid-glycolic acid copolymer (75:25, Mw=15000) and 200mg of teriparatide, dissolve it in 40mL of dichloromethane as the dispersed phase; slowly add the above dispersed phase in a water bath at 10°C Put it into 200mL aqueous solution containing 2% polyvinyl alcohol, emulsify for 1 hour, the emulsification condition is 1000 rpm, stir while adding; add the obtained emulsion into 500mL aqueous solution containing 0.2% polyvinyl alcohol, the temperature is 25 ℃, stir The organic solvent was volatilized in 4 hours to form solidified microspheres; the solution obtained above was collected by centrifugation at 3000 rpm, washed three times with purified water to remove the drug and polyvinyl alcohol on the surface of the microspheres, and dried in vacuum for two days to obtain Teriparatide extended-release microspheres.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
quality scoreaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of medicines, and in particular relates to a teriparatide sustained-release microsphere and a preparation method thereof. The teriparatide sustained-release microsphere comprises a teriparatide and a carrier, wherein the particle size of the teriparatide is 30 micrometers-50 micrometers; and the carrier is a mixture of one or two of polyester, starch, gelatin, Arabic gum, albumin, alginate and chitosan. The teriparatide microsphere is prepared by adjusting the constitution and molecular weight of the carrier and the medicine-loading rate and particle size of the microsphere according to the properties of the teriparatide. The prepared microsphere is stable in releasing and small in sudden releasing, the dose administration times can be reduced, the probability of infection is decreased, patients can conveniently take the microsphere, and the compliance of the patients is improved. Experiments show that the teriparatide has uniform particle size distribution, high encapsulation efficiency and large medicine-loading capacity. The sustained-release microsphere can be externally released for 10 days.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a teriparatide sustained-release microsphere and a preparation method thereof. Background technique [0002] Teriparatide, English name Teriparatide, is the biologically active N-terminal region of the human parathyroid hormone (PTH) peptide sequence. The complete human parathyroid hormone contains 84 amino acids, and teriparatide is a polypeptide fragment composed of 1 to 34 amino acids located in the N-terminal region. The molecular formula is C 181 h 291 N 55 o 51 S 2 , the molecular weight is 4177.77. [0003] Endogenous parathyroid hormone is a major regulator of calcium and phosphorus metabolism in bone and kidney. PTH increases the calcium concentration in serum, and with the increase of calcium concentration, the absorption of calcium by bone also partially increases. Long-term elevation of PTH depletes bone stores. But intermittent exposure to PTH activates oste...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/29A61K9/16A61K9/10A61K47/42A61K47/36A61K47/34A61P5/18
Inventor 徐春莲郑春莲马亚平袁建成
Owner HYBIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com